Ventilator-induced Diaphragm Dysfunction: from Theory to Clinical Trials
Speaker: Joseph Shrager

Join us for an Integrated Management Symposium to explore how leaders across sectors are partnering to address multiple diseases of aging through integrated interventions and product innovation.

Interview with Carolyn Baglole, director of the new McGill Research Centre for Cannabis

Timely administration of appropriate antibiotics is essential to prevent death in patients with severe infections. Can healthcare teams “skip” drawing blood for bacterial cultures?

How exactly does a normal cell become a tumour?

Recognition for her sentinel contributions to the assessment of clinical competence and management of prescription drugs

PICH2GO is an exciting series of educational and networking events co-hosted this year by PICH and Shriners Hospitals for Children® – Canada.

Innate Immune Response in Diseased Brain: Lost in Translation
Invited Speaker: JASNA KRIZ, MD, PHD

Clinical studies are the foundation of evidence-based medicine and are critical for developing management strategies to improve outcomes for patients.

Come and join this forum to update your knowledge about women-specific issues in heart disease.

The RI-MUHC Trainee Committee and CTB Technology Platforms invite you to attend the Platform Expo on October 3, 2019.

MeDiC team raised funds for a new competition to benefit trainees as part of the MUHC Foundation’s Run for a Reason initiative

Researchers uncover new protein that plays key role in bacterial infections

Congratulations to Erwin Schurr for his new grant from the Canada Foundation for Innovation’s (CFI) John R. Evans Leaders Fund.

Scientists propose diagnostic tools to identify, and possibly limit, the effects of sarcopenia, a disease that significantly reduces the quality of life of the aging population

New Trends in Small Molecule Drug Discovery: Artificial Intelligence, Cancer-Cell Vulnerabilities and Immunology.

RI-MUHC student Hunter S. Shaw’s publication makes the cover, with a work of art from the Convergence Initiative

The Cancer Research Program at the RI-MUHC is pleased to invite you to join us for our 2nd annual exclusive vendor showcase

Effective September 1, 2019, he will assume the mandate previously held by Dr. Constantin Polychronakos.

Learn about our research from the lab to new treatments. Food, drinks and family-friendly activities.

Ranked first of 626 in the CIHR postdoctoral competition, in 2020 Claire Gizowski will be forging ahead with a prestigious international fellowship instead

Five-day event drew 50 graduate student research trainees and 30 faculty members from across Canada and the United Kingdom

LeishDerm:an HSP90 inhibitor-based formulation cures experimental cutaneous leishmaniasis by parasite killing and modulating host immune response
Speaker: Patrícia Sampaio Tavares Veras, MD, PhD

Immunotherapy for Early Stage Lung Cancer – Progress and Potential
Speaker: Dr. Patrick Forde

The Extracellular Vesicle Network is multi-disciplinary collaborative research group with a common addiction: understanding and exploiting the use of Extracellular Vesicles.